Fortis arm Escorts Heart Institute receives SEBI notice in funds diversion case

Fortis Healthcare on Friday said its subsidiary, EHIRCL, received the notice on April 15, 2021.Premium
Fortis Healthcare on Friday said its subsidiary, EHIRCL, received the notice on April 15, 2021.
1 min read . Updated: 16 Apr 2021, 12:29 PM IST Staff Writer

The management and board of the company are evaluating the notice received by EHIRCL, in consultation with its legal advisors, the company said.

Fortis Healthcare on Friday said that its subsidiary, Escorts Heart Institute and Research Center Ltd, has received a notice from capital markets regulator SEBI in the matter related to the alleged diversion of funds from the company by its erstwhile promoters.

"SEBI has issued a notice under Rule 4 of SEBI (Procedure for holding inquiry and imposing penalties) Rules, 1995 read with Section 15-I of Securities and Exchange Board of India Act, 1992 in the matter of Fortis Healthcare Limited to, among others, Escorts Heart Institute and Research Center Limited (EHIRCL)," Fortis Healthcare said in a regulatory filing.

Fortis Healthcare on Friday said its subsidiary, EHIRCL, received the notice on April 15, 2021.

"The management and board of the company that was newly constituted after NTK Ventures Pte Ltd (a wholly-owned subsidiary of IHH Healthcare Berhad) became promoters of the company, are evaluating the notice received by EHIRCL, in consultation with its legal advisors," Fortis Healthcare said.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Close